Vitamin D has a pivotal role in a many biological processes, including the maintenance of calcium homeostasis, cell differentiation and proliferation. Most of these actions are mediated by transcriptional regulation of target genes through vitamin D receptor (VDR), a member the steroid/thyroid hormone receptor superfamily. Thus, it is important to understand vitamin D biosynthesis into an active form that regulates VDR transcriptional functions. The active form of vitamin D, 1,25(OH) 2 D 3 , derived by vitamin D3 1alpha hydroxylase, 1(OH)ase in renal proximal tubule cells is a ligand for VDR. We have identified the 1(OH)ase gene, which uses a novel expression cloning method derived from VDR deficient mice that have excess amounts of active vitamin D3 in the serum. Identification of 1(OH)ase gene had lead us to understand not only the biological significance of active vitamin D3 synthesis, but also a novel mechanism of VDR-mediated transcriptional regulation. The gene expression of 1(OH)ase is positively and negatively regulated by parathyroid hormone (PTH) and active vitamin D3 respectively. In this review, we describe switching between positive and negative transcriptional modulation by the VDR, together with recent findings on the mechanisms of VDR-mediated epigenetic regulation in the 1(OH)ase gene.
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The calciotropic hormone 1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ] regulates many biological actions, including calcium homeostasis, cell differentiation and proliferation. 1, 2) It is metabolized in the liver and kidney by sequential hydroxylation to a seco-steroid derivate (Fig. 1 7) and to be activated by calciotropic peptide hormones such as parathyroid hormone (PTH) and calcitonin. 8, 9) Thus serum concentrations of 1,25(OH) 2 D are kept constant. Moreover, biochemical analysis of semi-purified 1(OH)ase enzyme suggests that 1(OH)ase belongs to the P450 family of enzymes. [10] [11] [12] However, it remains unclear what 1(OH)ase enzymatic activity involves through gene expression, since no identification of the 1(OH)ase gene has been achieved. To clarify the molecular mechanisms of the maintenance of serum calcium and 1,25(OH) 2 D 3 concentrations, it is essential to identify the 1(OH)ase gene.
Most of the biological actions of 1,25(OH) 2 D 3 are thought to be mediated by the vitamin D receptor (VDR), a member of a nuclear receptor superfamily acting as a ligand-inducible transcription factor ( Fig. 1 ). 13, 14) 1,25(OH) 2 D 3 is thought to exert its physiological effects through the VDR, leading to transcriptional regulation of target gene promoters. VDR dimerizes with the retinoid X receptor (RXR) and stably binds VDR response elements (VDREs) in ligand-induced transactivation. 13, 14) Positive VDREs are elucidated to contain a direct repeat of two consensus core motifs (AGGTCA) with a 3-bp spacer (DR3). 13, 14) Ligand-induced transactivation by VDR couples with co-regulator switching, in that co-activator recruitment is coupled to co-repressor dissociation. 15, 16) Many nuclear receptors have been found to interact physically with other classes of DNA binding activators in ligandinduced transrepression. [17] [18] [19] In such aspects, no binding function of their cognate DNA binding sequences for transactivation in nuclear receptors is required. 20) Even though such models of ligand-induced transrepression by nuclear receptors have been proposed for the target genes, 21) it remained unclear until when how liganded VDR accesses the target gene promoter and induces transrepression.
To address these issues, we generated a novel cloning method using an expression cDNA library in the mouse kidney, and identified the cDNA and genome encoding Award Review 1(OH)ase. Then we clarified its gene regulation mediated by the VDR complex with co-regulators in a vitamin D3-dependent manner. Finally, we tried whether gene regulation in 1(OH)ase is affected by epigenetic control at the histone modification and DNA methylation.
I. Identification and Characterization of the 1(OH)ase Gene
Biochemical characterization of enzymatic activities of the 1(OH)ase has been demonstrated well in rat kidney from 1970s. 6,7) However, 1(OH)ase cDNA has never been identified by the characteristics of the enzymatic properties which is generally less active, and down-regulated in the high concentration of serum calcium and active vitamin D3, 1,25(OH) 2 D 3 . Meanwhile, although the VDR function has also been investigated intensively by in vitro analysis and cell lines systems, it remains unclear whether these findings reflect the function of VDR in intact animals. Thus, we established VDR deficient (VDR KO) mice with hypocalcemia and alopesia mimic vitamin D-dependent rickets type II in humans. 22) VDR KO mice showed a significantly elevated serum concentration of 1,25(OH) 2 D. Based on this evidence, we have suggested that 1(OH)ase gene expression and its activities are stimulated in VDR KO mice kidney. Therefore cDNA cloning of the 1(OH)ase gene was performed using these mice. To identify the cDNA encoding 1(OH)ase, first we developed a nuclear receptormediated expression system (Fig. 2) . This system is based on the fact that a precursor of 1,25(OH) 2 D 3 , 25(OH)D 3 , can activate the transactivation function of the VDR only in the presence of 1(OH)ase activity. A cDNA library from VDR KO mice kidney with an expression vector encoding a chimeric protein that included the VDR ligand domain (DEF) fused to the yeast GAL4 DNA-binding domain [GAL4-VDR(DEF)], and a reported plasmid bearing lacZ regulated by the GAL4 DNA-binding site (17M2G-lacZ), were transfected into COS-1 cells. In addition, because 1(OH)ase is known to be a mitochondrial P450, cDNAs encoding two P450 protein coenzymes, adrenodoxin (ADX) and adrenodoxin reductase (ADR), were added. When 25(OH)D 3 was added to the medium, VDR was activated only in cells expressing 1(OH)ase. Positively stained cells by -galactosidase staining were harvested by micromanipulation and analyzed by PCR. We had success in identifying the full-length cDNA facilitating VDR transcriptional activity in the presence of precursor, and then we identified the candidate cDNA as 1(OH)ase. 23) At the same time in 1997, several groups using RT-PCR methods reported the cloning of cDNAs encoding rat and human 1(OH)ase, confirming the previously described biochemical characterization of 1(OH)ase as a cytochrome P450. 24, 25) The predicted amino acid sequences revealed that 1(OH)ase proteins harbor a mitochondrial target signal and two conserved regions (the sterol-binding domain and the heme-binding domain), and show significant homology throughout the entire amino acid sequence with P450 enzymes. Indeed, mouse 1(OH)ase exhibited the greatest homologies to vitamin D hydroxylases, which belong to the mitochondrial P450 family: 41.7% homology to rat vitamin D 3 -25-hydroxylase (CYP27A1), and 31.6% homology to the mouse 25(OH)D 3 -24-hydroxylase Kidneys from mice lacking the VDR (VDR KO mice), which have predictably excessive 1(OH)ase activity, were used to prepare an expression library with expression vector pcDNA3 in COS-1 cells. The cells were then transfected with another vector expressing a chimeric protein that includes the VDR ligand-binding domain, VDR(DEF) fused to the yeast GAL4 DNA-binding domain GAL4-VDR(DEF) and with a reporter plasmid bearing lacZ regulated by the GAL4 binding site (17M2-G-lacZ). When supplied with 25(OH)D 3 , cells expressing 1(OH)ase would produce ligands that are able to activate GAL4-VDR(DEF) and would be identifiable by expression of -galactosidase (-Gal). After transfection, 25(OH)D 3 was added to the media. After 36 h, positive cells were detected by X-Gal staining.
(CYP24). 26, 27) The P450 nomenclature for 1(OH)ase is currently CYP27B1. 28) The organization of the human and rodent 1(OH)ase genes comprises nine exons extending over 5 kbp, 29, 30) and also resembles these promoters.
Northern blot analysis using cloned cDNA indicated that the 1(OH)ase gene is expressed abundantly in the kidney, while expression was almost undetectable in the extra-renal tissues of mice and humans. Quantitative RT-PCR analysis suggested that the 1(OH)ase gene is expressed in many extrarenal tissues at very low levels. While the renal activity of 1(OH)ase is positively regulated by calciotropic hormones, responding to serum calcium levels, 1,25(OH) 2 D 3 has been characterized as a negative regulator of the renal activity of 1(OH)ase. 8, 9) One study of ours using VDR KO mice indicated that 1,25(OH) 2 D 3 acts at the transcriptional level, and that this negative regulation requires liganded VDR, since gene expression of mouse 1(OH)ase is remarkably up regulated in VDR KO mice. Thus, it is likely that the negative regulatory region for VDR recognition, but not the positive region, on the 1(OH)ase gene promoter subsistent to recruits liganded VDR (Fig. 3 ).
II. Positive and Negative Regulation of the 1(OH)ase Gene by Calciotropic Hormones and Active Vitamin D3
To determine the transcriptional start site and regulatory regions of this gene promoter, primer extension analysis was performed with purified RNA from normal human kidney. We identified a TATA box and a negative regulatory element to 1,25(OH) 2 D 3 , although there are neither consensus negative VDREs nor significantly related sequences for nuclear receptors. [31] [32] [33] [34] On luciferase analysis using this promoter, overexpression VDR along with RXR potentiated this negative regulation by 1,25(OH) 2 D 3 . 35) However, gelshift analysis with recombinant VDR/RXR proteins indicated that no binding occurred directly in this negative VDRE. 35) In contrast, unknown factors from nuclear extracts in mouse renal proximal tubular cells were found to bind there. 35) Next, to isolate the binding factor in this region, a yeast one-hybrid assay using a negative VDRE (1nVDRE) was employed to screen an expression cDNA library derived from MCT cells. Seven candidates were identified, of which five represented overlapping sequences that encoded a protein, designated VDIR. 35) VDIR was found to be a basic helix-loop-helix-type transcription factor, and appeared to be a mouse homolog of human E47. 36) Based on these findings, it was hypoyhesized that VDIR is able to control gene expression by negative and positive regulation.
Calciotropic hormones, such as PTH and calcitonin, are known to induce the activity of 1(OH)ase, and cAMP has been found to be involved in this positive regulation by PTH, suggesting the possible involvement of the protein kinase A (PKA) signaling pathway in positive regulation. 37, 38) These findings were further supported by the observations to the effect that the 1(OH)ase gene promoters in humans and mice retain positive responses on PTH and calcitonin. 39) Indeed, by RT-PCR analysis, we found that differential regulation of 1(OH)ase activity by PTH, calcitonin, and 1,25(OH) 2 D 3 , occurs at the transcriptional level in intact animals as well as the MCT cell line of the mice kidney. 40) Moreover, the identification of 1(OH)ase promoter had lead us the attempt to demonstrate the considering that these hormones directly control the transcriptional activities through kinase cascade as cellular signal transduction. Indeed, the phosphorylation of VDIR was shown by activated PKA on forskolin treatment. 35) Phosphorylated VDIR associated with p300 as a histone acetyltransferase (HAT) coactivator, and then induced the transcriptional activities. Finally, we confirmed by Chromatin immunoprecipitation (ChIP) analysis that VDIR with p300 is stable on the VDIR binding site in the endogenous 1(OH)ase gene promoter in MCT cells. 35) In contrast, as expected in view of decreasing 1(OH)ase expression due to 1,25(OH) 2 D 3 treatment, it was also mediated by transcriptional repression, in which VDIR forms a ternary complex with VDR/RXR (Fig. 4) . 35) 
III. Molecular Mechanisms of Negative Regulation by Active Vitamin D3
The next question was how VDR in the presence of vitamin D3 leads transrepression of the 1(OH)ase gene. To gain insight into ligand-induced VDR transrepression of the VDIR function, we examined to determine whether co-repressor complexes associate with VDIR through ligand-induced interaction with VDR, thereby suppressing transcription, and whether p300 co-activators dissociate from VDIR upon interaction with liganded VDR. Measurement of HAT and HDAC activities in VDIR immunoprecipitates showed that the highest HAT activity occured when PKA signaling was activated by forskolin treatment. 1,25(OH) 2 D 3 treatment significantly reduced HAT activity, as reflected by the dissociation of p300 and the acquisition of HDAC activity. 35) At the same time, several major HDAC co-repressor components, including N-CoR, HDAC2, and Sin3A, were co-immunoprecipitated with VDIR in a vitamin D3 dependent manner, and were recruited to the 1(OH)ase promoter, as shown by ChIP analysis. 35) These findings indicate that upon activated-PKA signaling due to PTH, the 1(OH)ase gene is transactivated through recruitment of a HAT co-activator complex to VDIR bound to 1nVDRE, leading to increased serum 1,25(OH) 2 D 3 concentrations (Fig. 4 ). 1,25(OH) 2 D 3 binding to VDR induces association with VDIR, and leads to dissociation of the HAT co-activator complex and association of the HDAC co-repressor complex. This results in ligand-induced transrepression of the 1(OH)ase gene due to co-regulator switching on VDIR (Fig. 4) .
However, treatment with TSA, a HDAC inhibitor, did not fully abrogate 1,25(OH) 2 D 3 induced transrepression by VDR/VDIR, suggesting that it is impossible to explain transcriptional switching by modification of histone acetylation on the 1(OH)ase gene promoter. 41) Hence, to clarify the mechanisms of transcriptional switching, we examined protein complex purification using VDIR with a FLAG-tag peptide to identify the association components, which function to contribute during histone deacetylation and other epigenetic modulations.
IV. Epigenetic Regulations of Positive and Negative Transcription in the 1(OH)ase Gene
The association states of VDIR and VDR consisted of several complexes when fractionated on an ionexchange column and a glycerol gradient. We identified DNA methyltransferases 1 and 3B (DNMT1 and DNMT3B) as their interactants with DNMT activity. 42) In general, DNMT family members are well known to methylate cytosines at specific DNA sequences to repress transcription. 43) Thus, our findings suggest that DNA methylation of the CpG sites in the promoter and coding regions of the 1(OH)ase gene, as well as histone deacetylation, are induced by 1,25(OH) 2 D 3 to repress Upon activated-PKA signaling due to PTH, the 1(OH)ase gene is transactivated through recruitment of the HAT co-activator complex to VDIR bound to 1nVDRE, leading to increased serum concentrations of 1,25(OH) 2 D 3 . 1,25(OH) 2 D 3 binding to VDR induces association with VDIR, and leads to dissociation of the HAT co-activator complex and the recruitment of an HDAC co-repressor complex. This results in ligand-induced transrepression of the 1(OH)ase gene due to co-regulator switching on VDIR. Vitamin D3 signaling induces DNA methylation on the 1(OH)ase gene promoter. In contrast, in PTH stimulation, DNA demethylation of this promoter is raised by glycosylase activity of MBD4 by PKC-mediated phosphorylation. This suggests that the switching between positive and negative transcriptional modulation in 1(OH)ase gene is involved in the regulation of DNA demethylation and methylation in addition modification of histone acetylation. gene expression. Indeed, these regions in this promoter have proved contain CpG sequences. On luciferase assay, DNMT1 and DNMT3B acted as co-repressors for ligand-induced transrepression of the 1(OH)ase promoter. 42) Biochemical purification of a complex associated with VDIR has included coincidentally a DNA glycosylase, MBD4. 42) MBD4 belongs to the 5-methyl-CpG binding domain (MBD) family, which is implicated in transcriptional repression. Unlike other MBD family members, MBD4 functions in DNA repair as a thymine glycosylase to remove T/G mismatches generated after the deamination of 5-methyl-citosine. 44, 45) Therefore, we characterized MBD4 further, because MBD4 recruitment to the promoter coincided with the state of DNA methylation.
By ChIP analys, it was confirmed that a protein complex of VDIR/VDR with DNMTs occurred on the promoter in a vitamin D3 dependent manner. 42) In contrast, while MBD4 was immunoprecipitated with VDIR in the presence of 1,25(OH) 2 D 3 , it remained associated after co-treatment with 1,25(OH) 2 D 3 and PTH was independent of the dissociation of DNMTs from VDIR. 42) VDIR appeared to be indispensable for MBD4 recruitment to the promoter, presumably through physical association. It is well known that PTH signaling activates not only PKA, but also PKC. 46) Interestingly, PKC activated by PTH stimulation induced MBD4 phosphorylation, and then promoted incision of methylated DNA through glycosylase activity, and a baseexcision repair process appeared to complete DNA demetylation in the MBD4-bound promoter. Moreover, PTH induced-DNA demetylation and subsequent transcriptional derepression were impaired in a MBD4 knock-out mice, confirming the in vitro observations. Thus our findings support that switching between positive and negative transcriptional modulation in the 1(OH)ase gene is involved in the regulation of DNA demethylation and methylation in addition modification of histone acetylation.
V. Concluding Remarks
Our consistent data were derived from identification of the 1(OH)ase gene, active vitamin D3 biosynthesis, and how gene regulation of it is controlled by calciotropic hormones and vitamin D3. Gene regulation appears to be modulated by dual modifications of histone acetylation and DNA methylation caused by VDIR-mediated complex components on this promoter. In general, rapid alterations of chromatin structure are required for initiation of gene expression by hormones or cytokine stimulation. 47) Rapid regulation of the 1(OH)ase gene is also essential for vitamin D3 biosynthesis to maintain serum calcium homeostasis, suggesting that epigenetic switching between histone deacetylation and acetylation, and DNA methylation and demethylation is consistent with the formation of nonconstructive heterochromatin, but not constitutive heterochromatin. We anticipate that these findings will serve as fundamentals not only in clarifying gene regulation by vitamin D3, but also in understanding transcriptional regulation in general through epigenetic modulation.
